GW RhythmX Launches RhythmX Pulse on Microsoft Marketplace, Integrating Precision Care AI with Dragon Copilot
核心洞察
GW RhythmX (搜索) announced RhythmX Pulse is now available on Microsoft (搜索) Marketplace, enabling seamless deployment for health systems already using Dragon Copilot.
RhythmX Pulse transforms captured clinical encounters into real-time, patient-specific recommendations by analyzing medical history, guidelines, payer rules, and formulary data.
The platform has completed over 170,000 physician-reviewed clinical validations and is deployed across more than 150 health systems reaching over 85 million patients.
PALO ALTO, Calif. — GW RhythmX (搜索) announced on July 15, 2026, that its Precision Care AI platform, RhythmX Pulse, is now available on Microsoft (搜索) Marketplace, the unified online destination for customers to purchase trusted cloud solutions, AI applications, and agents. The integration allows health systems already using Microsoft's Dragon Copilot to add RhythmX Pulse directly through the marketplace with no separate implementation required, marking a significant step toward embedding real-time, patient-specific clinical decision support at the point of care.
RhythmX Pulse builds on Dragon Copilot's existing capability to automatically capture patient encounters. The platform then cross-references that captured encounter against a comprehensive set of patient-specific data — including medical history, current medications, clinical guidelines, social context, payer rules, formulary requirements, and care gaps — to surface personalized, actionable recommendations before the patient leaves the room.
"Clinical AI is more than summarization or guideline lookups. Now Dragon Copilot users can get the validated and hyper-personalized guidance they need to deliver frontier precision care in every encounter," said Deepthi Bathina, founder and CEO of GW RhythmX (搜索). "Through Dragon Copilot, GW RhythmX checks that encounter against a patient's full history, the latest guidelines, social and financial intelligence and payer and formulary rules, so clinicians get a clear next best action instead of just a summary or generic guidance."
Clinical Decision Support at the Point of Care
The recommendations generated by RhythmX Pulse span multiple domains critical to clinical practice. These include documentation improvements, care-gap alerts, HCC and coding opportunities, guideline-based treatment options, and formulary-aware medication alternatives — each supported by underlying evidence. Clinicians retain full autonomy, with the ability to accept, edit, or dismiss any recommendation surfaced by the platform.
Prasanna Mohanty, EVP & President of Ambulatory Care at Sentara Health, underscored the clinical significance of the integration: "Microsoft (搜索) Dragon has already helped reduce the documentation burden and give clinicians more time to focus on patients. The next major opportunity is to use the clinical context captured during the encounter to support more personalized decisions at the point of care. Integrating Precision Care AI can help bring relevant history, guidelines, and other patient-specific factors into the decision-making process while the patient is still in the room."
Validation and Scale
GW RhythmX (搜索) has completed more than 170,000 physician-reviewed clinical validations to date, with physician-led governance and quality assurance embedded into every recommendation the platform surfaces. The company, formed through the merger of Get Well and RhythmX AI, operates as a SymphonyAI Group (搜索) company and draws on more than $1 billion in R&D investment. Its solutions are deployed across more than 150 health systems, reaching over 85 million patients — including 8 million U.S. military veterans — with longitudinal data spanning 300 million patients, 4.4 billion annual claims, and 1.8 million healthcare professionals across more than 3,000 facilities globally.
"We're pleased to welcome GWRhythmX to Microsoft (搜索) Marketplace," said Cyril Belikoff, vice president of Microsoft Azure Product Marketing. "Marketplace connects trusted solutions from global partners with customers worldwide, making it easy to find and deploy apps that work seamlessly with Microsoft products."
Future Roadmap
The current launch represents the first phase of a broader collaboration between GW RhythmX (搜索) and Microsoft (搜索). Planned future capabilities aim to extend clinically validated recommendations across the full care continuum, including pre-visit preparation, real-time conversational guidance during encounters, care-team coordination, and longitudinal patient management — positioning the platform to support clinicians before, during, and after each patient interaction.
GW RhythmX (搜索)'s solutions were recognized in 2024 by KLAS Research, Fierce Healthcare, and AVIA Marketplace, reflecting the company's growing footprint in the AI-enabled precision care and patient engagement landscape.